The electrophysiology market was valued at USD 7.2 billion in 2021 and it is anticipated to reach up to USD 16.9 billion by 2031, at a CAGR of 8.9% during the forecast period.
Atrial and ventricular fibrillation, tachycardia, and other diseases that have an impact on the heart are mostly diagnosed and treated with electrophysiology equipment. Healthcare professionals use a variety of tools based on the electrophysiological technique to identify and treat various disorders, including ablation and diagnostic catheters, mapping systems, etc.
Download Free Sample of Report – https://www.globalinsightservices.com/request-sample/GIS10275
Market Trends and Drivers
The increasing incidence of target diseases and procedures is boosting the growth of the market. According to the WHO, CVD is the largest global cause of death. Age, race, and family history are significant factors influencing the increased prevalence of CVD and strokes. Other risk factors include using tobacco, having high blood pressure (hypertension), having high cholesterol, being obese, being physically inactive, having diabetes, eating unhealthily, and drinking alcohol. The prevalence of CVD is on the rise in part due to conditions like hypertension, diabetes, dyslipidemia, and obesity. By 2030, the American Heart Association projects that 41.4% of US individuals will have hypertension (an increase of 8.4 percent from 2012). Additionally, according to the organization, the cost of CVD will increase from USD 863 billion in 2010 to USD 1,044 billion by 2030. Globally, 17.9 million people passed away from CVD in 2016. According to projections, this number will reach 23.6 million by 2030.
The American Heart Association (AHA) claims that catheter-based ablation techniques have a 90% success rate, and minimal risk of complications, and allow patients to return to their regular activities in a few days.
The limited effectiveness of anti-arrhythmic medications in the management of arterial filtration is another factor boosting catheter ablation demand. A study titled Radiofrequency Ablation vs. Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT 2) presented its findings in Massachusetts (US) in May 2012 at the Heart Rhythm Society meeting, concluding that ablation of AF, when used as a first-line method, was superior to medications that control rhythm.
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS10275
Market Segments
By Product Type
- Electrophysiology Ablation Catheters
- Electrophysiology Laboratory Devices
- Electrophysiology Diagnostic Catheters
- Electrophysiology Access Devices
- Others
By Indication Type
- Atrial Fibrillation
- Atrial Flutter
- Atrioventricular Nodal Reentry Tachycardia
- Wolf-Parkinson-White Syndrome
- Others
By End Users
- Hospitals & Cardiac Centers
- Ambulatory Surgery Centers
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of World
- Latin America
- Middle East
- Africa
Purchase This Market Research Report – https://www.globalinsightservices.com/checkout/single_user/GIS10275
Major Players in the Global Electrophysiology Market
The key players studied in the global electrophysiology market are Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthcare GmbH (Germany), Stereotaxis, Inc. (US), Merit Medical Systems (US), Atricure Inc. (US), APN Health, LLC (US), Osypka Medical (Germany), Japan LifeLine Co., Ltd. (Japan), Johnson & Johnson (US), Biotronik (Germany), MicroPort Scientific Corporation (China), Acutus Medical, Inc. (US), Lepu Medical Technology (Beijing), CathRx Ltd. (Australia), Cook Medical (US), CathVision ApS (Denmark), TZ Medical (US), Teleflex Incorporated (US), Imricor (US), CardioFocus (US), Schwarzer Cardiotek GmbH (Germany), Kardium (Canada), EP Solutions SA (Switzerland), BioSig Technologies Inc. (BSGM) (US), Coremap (US), and EPMap System GmbH (Germany).
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, USA. We are committed to providing the highest quality data, analytics and tools to meet all of our clients’ market research needs. With GIS, you can be assured of the quality of your output, robust and transparent research methodology, and excellent service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
Email: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/